Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 21:28:625-632.
doi: 10.1016/j.reth.2025.02.005. eCollection 2025 Mar.

Platelet concentrates in diabetic foot ulcers: A comparative review of PRP, PRF, and CGF with case insights

Affiliations

Platelet concentrates in diabetic foot ulcers: A comparative review of PRP, PRF, and CGF with case insights

Mengling Yang et al. Regen Ther. .

Abstract

Diabetic foot ulcers (DFUs) are severe complications of diabetes, often leading to chronic wounds, amputations, and increased mortality risk. Platelet concentrates (PCs)-natural biomaterials utilized in regenerative medicine-have garnered attention for their capacity to enhance tissue repair and wound healing. This study reviews the preparation methods, biological mechanisms, and clinical efficacy of three generations of PCs: platelet-rich plasma (PRP), platelet-rich fibrin (PRF), and concentrated growth factors (CGF). Comparative analysis reveals that PRP, the first generation, provides abundant growth factors but relies on anticoagulants, which may hinder fibrin formation and tissue adhesion. PRF, as the second generation, eliminates anticoagulants, forming a fibrin matrix that sustains growth factor release and enhances cell migration. CGF, the latest advancement, employs refined centrifugation to achieve higher growth factor concentrations and a denser fibrin matrix, accelerating tissue regeneration. Case series results demonstrated superior wound healing outcomes with CGF, including faster epithelialization and reduced healing time compared to PRP and PRF. These findings underscore CGF's potential as the most effective PC for managing DFUs, supporting its broader clinical adoption in advanced wound care.

Keywords: Concentrated growth factors; Diabetic foot ulcers; Platelet concentrates; Platelet-rich fibrin; Platelet-rich plasma; Wound healing.

PubMed Disclaimer

Conflict of interest statement

The authors have declared no conflict of interest.

Figures

Fig. 1
Fig. 1
PRP, PRF, and CGF preparation process.
Fig. 2
Fig. 2
PRP treatment for DFU patient with osteomyelitis. a) Ulceration, redness, and swelling with pain in the fifth toe of the left foot. b) after PRP treatment, the wound healed well.
Fig. 3
Fig. 3
CGF treatment for elderly DFU patient with severe infection. a) Long-term non-healing of the foot wound after enucleation of necrotic tissue, accompanied by oozing and pus flow. b) treatment with CGF. c) the wound healed well and the limb was successfully preserved.

References

    1. Li Y., Ye Z., Yang W., Zhang Q., Zeng J. An update on the potential of mesenchymal stem cell therapy for cutaneous diseases. Stem Cell Int. 2021 doi: 10.1155/2021/8834590. - DOI - PMC - PubMed
    1. Gurtner G.C., Chapman M.A. Regenerative medicine: charting a new course in wound healing. Adv Wound Care. 2016 doi: 10.1089/wound.2015.0663. - DOI - PMC - PubMed
    1. Grennan D. Diabetic foot ulcers. JAMA. 2019;321:114. doi: 10.1001/jama.2018.18323. - DOI - PubMed
    1. Armstrong D.G., Tan T.-W., Boulton A.J.M., Bus S.A. Diabetic foot ulcers: a review. JAMA. 2023;330:62. doi: 10.1001/jama.2023.10578. - DOI - PMC - PubMed
    1. Armstrong D.G., Boulton A.J.M., Bus S.A. Diabetic foot ulcers and their recurrence. N Engl J Med. 2017;376:2367–2375. doi: 10.1056/NEJMra1615439. - DOI - PubMed

LinkOut - more resources